ALQGC — Quantum Genomics SA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Quantum Genomics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | — | — |
| Source: | ARS | ARS | ARS | ||
| Standards: | FAS | FAS | FAS | — | — |
| Status: | Final | Final | Final | fx Preliminary | fx Preliminary |
| Net Income/Starting Line | -11.5 | -16.6 | -24.9 | — | — |
| Depreciation | |||||
| Non-Cash Items | 0.001 | 0 | 0.451 | — | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.592 | -0.59 | 9.51 | — | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -12 | -16.9 | -15 | — | — |
| Capital Expenditures | -0.411 | -0.045 | -0.033 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.17 | 0.018 | -0.12 | — | — |
| Change in Net Investments | |||||
| Cash from Investing Activities | -0.581 | -0.028 | -0.153 | — | — |
| Financing Cash Flow Items | -0.001 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 28.5 | 3.29 | 17.2 | — | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16 | -13.6 | 2.09 | — | — |